Gut microbiota: An overlooked target in dyslipidemia management

doi:10.3748/wjg.v31.i48.113178

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 48

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (584)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

HTML

355

Figures (1-1)

Sum=389

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

116

Sum=155

Dec 28, 2025 (publication date) through Feb 13, 2026

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Gastroenterol. Dec 28, 2025; 31(48): 113178
Published online Dec 28, 2025. doi: 10.3748/wjg.v31.i48.113178

Gut microbiota: An overlooked target in dyslipidemia management

Ammara Abdul Majeed, Amna Subhan Butt

Ammara Abdul Majeed, Amna Subhan Butt, Department of Medicine, Aga Khan University Hospital, Karachi 74800, Pakistan

Author contributions: Majeed AA and Butt AS both reviewed the article, performed literature search and wrote the letter to the editor; Butt AS received the invitation for letter to the editor.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Corresponding author: Amna Subhan Butt, Associate Professor, Department of Medicine, Aga Khan University Hospital, Stadium Road, Karachi 74800, Pakistan. amna.subhan@aku.edu

Received: August 18, 2025
Revised: October 1, 2025
Accepted: November 3, 2025
Published online: December 28, 2025
Processing time: 131 Days and 13.2 Hours

Core Tip

Core Tip: Dyslipidemia has emerged as a leading modifiable risk factor for atherosclerotic, cardiovascular and hepatic diseases. Gut microbiota lipid metabolism interactions offer new opportunities for dyslipidemia management, but translating these insights into clinical practice requires more than compositional profiling. This letter emphasizes overlooked dimensions like circadian rhythm alignment, drug-microbe crosstalk, population-specific microbial patterns, and functional microbial signatures to guide precision, and context-aware strategies for cardiovascular risk reduction.